Filing Details
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PHAT
Phathom Pharmaceuticals, Inc. (PHAT) Files Quarterly Report for Q0
Filing Details Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026. The Healthcare…
Market Context
Phathom Pharmaceuticals, Inc.'s stock currently trades at $9.03 with a market capitalization of $1.0B.
The 10-Q provides Phathom Pharmaceuticals, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Phathom Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PHAT Stock Page
Frequently Asked Questions
Where can I read PHAT's SEC filings?
Browse all filings on our PHAT SEC filings page.
What types of SEC filings does Phathom Pharmaceuticals, Inc. file?
Public companies like Phathom Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.